OrbiMed’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$376K Hold
80,420
0.01% 96
2025
Q1
$442K Hold
80,420
0.01% 105
2024
Q4
$273K Hold
80,420
0.01% 111
2024
Q3
$229K Hold
80,420
﹤0.01% 109
2024
Q2
$181K Hold
80,420
﹤0.01% 107
2024
Q1
$178K Buy
+80,420
New +$178K ﹤0.01% 112